MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Immunotherapy responsive malignancy

 Systemic Anti-Cancer Therapy (SACT) guidance including pathways for managing complications and adverse events directly linked to SACT which may present both in emergency departments and on the general wards. This covers both chemotherapy and immune related toxicities.